Name
Alexion, AstraZeneca Rare Disease
What We Do
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines.
Website
Categories (6)
Biotechnology, General Neurology, Neuromuscular, Pharmaceutical